Else Nutrition Holdings Inc (BABYF)

[pual]

'In Q4 2021 Else concluded a successful preclinical safety study'.

'The study results will be presented in ... meetings focused on pediatric nutrition and will be published in scientific peer-reviewed journals'.

Else is in close communication with the FDA ... to receive their guidance throughout the process of Else’s infant formula development'.

'Else also worked on preparations for the three clinical studies ... we plan to continue our research activity ... as well as provide scientific support for our products including preparations for additional clinical studies'.

That is a great definition of HALF THE MANDATE our management should commit to.

Looking forward to learn about the other half ...